Francis Gabriel Moussy

Francis Gabriel Moussy

Auto-generated profile, based on publicly available information

Francis Gabriel Moussy

Department of Essential Medicines and Health Products, World Health Organisation

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 May 2012 in Sensors
Verified
Journal Article
Open access
PDF file
ZZZhigang Zhu
Zhigang Zhu
LGLuis Garcia-Gancedo
Luis Garcia-Gancedo
AFAndrew J. Flewitt
Andrew J. Flewitt
HXHuaqing Xie
Huaqing Xie
FMFrancis Moussy
Francis Moussy
WMWilliam I. Milne
William I. Milne
There has been an explosion of research into the physical and chemical properties of carbon-based nanomaterials, since the discovery of carbon nanotubes (CNTs) by Iijima in 1991. Carbon nanomaterials offer unique advantages in several areas, like high surface-volume ratio, high electrical conductivity, chemical stability and strong mechanical strength, and are thus frequently being incorporated into sensing elements. Carbon nanomaterial-based sensors generally have higher sensitivities and a lower detection limit than conventional ones. In this review, a brief history of glucose biosensors is firstly presented. The carbon nanotube and grapheme-based biosensors, are introduced in Sections 3 and 4, respectively, which cover synthesis methods, up-to-date sensing approaches and nonenzymatic hybrid sensors. Finally, we briefly outline the current status and future direction for carbon nanomaterials to be used in the sensing area.

8 August 2012 in Sensors
Verified
Journal Article
Open access
PDF file
SCSandro Carrara
Sandro Carrara
SGSara Ghoreishizadeh
Sara Ghoreishizadeh
JOJacopo Olivo
Jacopo Olivo
ITIrene Taurino
Irene Taurino
CBCamilla Baj-Rossi
Camilla Baj-Rossi
GMGiovanni De Micheli
Giovanni De Micheli
Recent advances in microelectronics and biosensors are enabling developments of innovative biochips for advanced healthcare by providing fully integrated platforms for continuous monitoring of a large set of human disease biomarkers. Continuous monitoring of several human metabolites can be addressed by using fully integrated and minimally invasive devices located in the sub-cutis, typically in the peritoneal region. This extends the techniques of continuous monitoring of glucose currently being pursued with diabetic patients. However, several issues have to be considered in order to succeed in developing fully integrated and minimally invasive implantable devices. These innovative devices require a high-degree of integration, minimal invasive surgery, long-term biocompatibility, security and privacy in data transmission, high reliability, high reproducibility, high specificity, low detection limit and high sensitivity. Recent advances in the field have already proposed possible solutions for several of these issues. The aim of the present paper is to present a broad spectrum of recent results and to propose future directions of development in order to obtain fully implantable systems for the continuous monitoring of the human metabolism in advanced healthcare applications.

1 May 2023 in Bulletin of the World Health Organization
Verified
Journal Article
Open access
WWWallace White
Wallace White
RKRigveda Kadam
Rigveda Kadam
FMFrancis Moussy
Francis Moussy
While equipment-free visual interpretation is a benefit of lateral-flow assays, automating the reading of rapid diagnostic tests promotes proper test performance, interpretation and reporting of the results. We have created a target product profile that describes the minimal and optimal characteristics of various rapid diagnostic test readers. The product profile is intended to promote the development of effective, useful, sustainable rapid diagnostic test readers in support of health programmes worldwide. These readers may be custom hardware or software-only running on a general-purpose mobile device, for professional or lay use, and for medical or non-medical purposes. During the development of the product profile, the World Health Organization and FIND convened a development group of 40 leading scientists, experts, public health officials and regulators. We held a public consultation to which 27 individuals or organizations responded. The product profile calls for rapid diagnostic test readers that at minimum should: (i) interpret colorimetric tests with at least 95% agreement with expert visual interpretation; and (ii) automatically report results and associated data for the health programme. Optimally, readers should: (i) provide at least 98% agreement; (ii) operate with multiple models of rapid diagnostic tests; (iii) assist the user in performing each rapid diagnostic test according to the test instructions; and (iv) offer multiple configurations, operating modes and languages to suit the needs of diverse users, settings and health programmes.

2 August 2010 in Journal of Biomedical Materials Research Part A
Verified
Journal Article
Closed access
PDF file
FMFrancis Moussy
Francis Moussy

31 May 2013 in Health and Technology
Verified
Journal Article
Closed access
PDF file
MNM. T. Novak
M. T. Novak
CKC. N. Kotanen
C. N. Kotanen
SCS. Carrara
S. Carrara
Anthony Guiseppi-ElieAnthony Guiseppi-Elie
Anthony Guiseppi-Elie
FMF. G. Moussy
F. G. Moussy

1 January 2013
Verified
Book Chapter
Closed access
PDF file
CKChristian N. Kotanen
Christian N. Kotanen
FMFrancis Gabriel Moussy
Francis Gabriel Moussy
SCSandro Carrara
Sandro Carrara
Anthony Guiseppi-ElieAnthony Guiseppi-Elie
Anthony Guiseppi-Elie